Daniel H. Rich
Professor of Medicinal and Organic Chemistry
University of Wisconsin - Madison
Brief 15 minute presentations from companies developing peptide therapeutics and related technologies. This rapid and compressed format is designed for quick introduction between symposium participants to new technologies, and companies. Each presentation is structured to highlight the value of the technology or therapeutic being offered and the business strategy.
Lauren Goodrich
Scientist
Roche Madison
Ratmir Derda
Ratmir
University of Alberta // 48Hour Discovery, Inc.
Victor Hruby
Victor
MCR Therapeutics
Alex Batchelor
Alex
Orbit Discovery Ltd
Brian Del Buono
Vice President
Stuart Therapeutics
Brief 15 minute presentations of applied research from the academic labs.
Mathieu Cinier
Scientific Director
Affilogic
Kimberly Kelly
Co-Founder and Partner
Blue Ridge Biosciences
Len Luyt
Len
University of Western Ontario
Pierre Bernard-Savary
President
Intl Symposium for HPTLC / Club de CCM / Chromacim
Updates on clinical development of peptide therapeutics.
Hazel Szeto
Scientific Founder
Stealth Biotherapeutics
Natalie Winblade Nairn
Director, Formulation and Peptide Drug Discovery
Blaze Bioscience
Dave Garman
Chief Technology Officer
NoNO Inc.
Jim Trevaskis
Principal Scientist
MedImmune
Novel approaches to peptide drug delivery including devices, molecular engineering, conjugation, and formulation technologies
Joel Richard
Senior Vice President, Peptides
IPSEN
Uli Binder
Chief Technology Officer
XL-protein GmbH
Timo Nuijens
Lead Scientist
EnzyPep
Wilfred Van der Donk
Professor of Chemistry
University of Illinois at Urbana-Champaign
Maria Luisa Mangoni
Associate Professor
University of Rome
Kate Carroll
Associate Professor
The Scripps Research Institute - Florida
Richard Houghten
Founder, CEO
Torrey Pines Institute for Molecular Studies
Pharm Development Panel discussion
